Rohto Pharmaceutical Co Ltd represents a set of values and corporate philosophy that focuses on improving people's lives through innovative healthcare products. The company is committed to providing safe, effective, and high-quality solutions to meet various medical and beauty needs. Rohto Pharmaceutical Co Ltd believes in continuous research and development, ensuring that their products are backed by scientific expertise. With a strong emphasis on customer satisfaction, the company aims to contribute to society by promoting better health and well-being. Rohto Pharmaceutical Co Ltd's dedication to excellence and its mission to enhance the lives of individuals make it a trusted name in the pharmaceutical industry.

Rohto Pharmaceutical Co Ltd is primarily present in Japan, its home country. As a leading pharmaceutical company, Rohto has established its presence and reputation domestically. With a strong focus on developing and marketing innovative healthcare products, Rohto has gained a significant market share in Japan. The company's commitment to providing high-quality healthcare solutions has made it a trusted brand among consumers in the region. Rohto continues to expand its operations and aims to bring its products to other countries and regions in the future.

Rohto Pharmaceutical Co Ltd, a renowned company in the pharmaceutical industry, has achieved several significant milestones. The company has successfully expanded its global presence through strategic partnerships and acquisitions, strengthening its position in the market. Rohto Pharmaceutical Co Ltd has also developed innovative and high-quality healthcare products, addressing various medical needs. With a focus on research and development, the company has made breakthroughs in the pharmaceutical sector, contributing to advancements in healthcare. Moreover, Rohto Pharmaceutical Co Ltd has gained recognition for its commitment to ensuring the well-being and satisfaction of its customers worldwide.

Rohto Pharmaceutical Co Ltd, founded in 1899, is a well-established Japanese healthcare company. With a rich history spanning over a century, the company has garnered a reputation for manufacturing and distributing innovative pharmaceutical products globally. Rohto Pharmaceutical specializes in developing healthcare solutions across various domains, including skincare, eye care, oral care, and pain relief. With a strong commitment to research and development, the company consistently delivers high-quality, reliable products that cater to diverse consumer needs. Over the years, Rohto Pharmaceutical has become synonymous with excellence in the healthcare industry, consistently striving to improve the overall well-being and health of individuals worldwide.

The main competitors of Rohto Pharmaceutical Co Ltd in the market include Johnson & Johnson, Pfizer Inc., Novartis International AG, and GlaxoSmithKline plc.

Rohto Pharmaceutical Co Ltd is primarily active in the healthcare and personal care industries.

The business model of Rohto Pharmaceutical Co Ltd revolves around developing, manufacturing, and marketing a wide range of innovative healthcare products. Rohto Pharmaceutical aims to contribute to the well-being of individuals by providing high-quality medicines, cosmetics, and functional foods. As a leading Japanese company in the pharmaceutical industry, Rohto Pharmaceutical focuses on research and development to create breakthrough solutions for various health concerns. With a strong commitment to improving people's lives, Rohto Pharmaceutical continues to expand its product portfolio while ensuring adherence to strict quality standards.

مُعامل القيمة السوقية إلى الأرباح لـ Rohto Pharmaceutical Co هو ١٦٫٥٣.

مُعامِل القيمة إلى المبيعات Rohto Pharmaceutical Co هو ١٫٧٣.

نقاط جودة AlleAktien لـ Rohto Pharmaceutical Co هي 9/10.

المتوقعة Rohto Pharmaceutical Co الإيرادات هي ٣١٦٫٦٦ مليارات JPY.

صافي الربح المتوقعة Rohto Pharmaceutical Co هو ٣٣٫٠٦ مليارات JPY.

Rohto Pharmaceutical Co Ltd is a Japanese company specializing in the manufacturing and sale of healthcare products. It was founded in 1899 and has its headquarters in Osaka, Japan. It is part of the Rohto-Mentholatum group and operates worldwide. The company's main divisions are ophthalmic, dermatological, and oral care products. In the ophthalmic division, Rohto Pharmaceutical holds a leading position in the Japanese market, offering eye drops, lens care products, and eye washes for both medical and cosmetic purposes. In dermatology, the company provides various skin creams, pain ointments, and lip balms to help with skin issues such as acne, eczema, psoriasis, and other irritations. Their oral care products include toothpaste, mouthwash, and gum. Rohto Pharmaceutical also offers a range of pain relievers for headaches, backaches, muscle pains, and menstrual discomfort, marketed under brand names such as "Zanidip" and "Sai-Ro." With a strong presence in the Asian market, Rohto Pharmaceutical continues to expand into North America and Europe. It has subsidiaries in China, Hong Kong, Taiwan, and Thailand, as well as branches in North America and Europe. The company has partnerships with local businesses in various countries and operates joint ventures to expand its global presence. Rohto Pharmaceutical's business model relies on innovation and quality control. It invests in research and development to develop new products and improve existing ones. The company also implements rigorous controls in all its production facilities to ensure its products meet the highest quality standards. Rohto Pharmaceutical holds multiple patents for its products and technologies. The company is known for its marketing strategies, prioritizing brand awareness and utilizing various media to promote its products. It also maintains a presence on social media and employs online marketing to sell its products. Rohto Pharmaceutical is expected to continue expanding and entering new markets. With a strong position in the Asian market, it is likely to focus on expanding in North America and Europe. Continued investment in research and development and the introduction of new products are also expected to drive the company's growth. Overall, the future of Rohto Pharmaceutical is promising, and it is expected to remain a significant player in the healthcare industry.

يوزع Rohto Pharmaceutical Co أرباحًا قدرها ٤١٫٠٠ JPY من خلال 2 عمليات توزيع موزعة على مدار السنة.

Rohto Pharmaceutical Co يوزع أرباحًا 2 مرة في السنة.

الرمز الدولي للأوراق المالية الخاص بـRohto Pharmaceutical Co هو JP3982400008.

رمز WKN لـ Rohto Pharmaceutical Co هو 858075.

الرمز المُختصر لـ Rohto Pharmaceutical Co هو 4527.T.

خلال آخر 12 شهراً، دفعت Rohto Pharmaceutical Co توزيعات أرباح بقيمة ٣١٫٠٠ JPY . وهذا يعادل عائد توزيعات أرباح يقارب ١٫٣٠ %. ومن المتوقع أن تدفع Rohto Pharmaceutical Co خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٣٣٫١٣ JPY.

نسبة توزيعات الأرباح الحالية لـ Rohto Pharmaceutical Co هي ١٫٣٠ %.

Rohto Pharmaceutical Co يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أكتوبر, أبريل, أكتوبر, أبريل.

Rohto Pharmaceutical Co دفعت توزيعات الأرباح كل عام خلال الـ23 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٣٣٫١٣ JPY. وهذا يعادل عائد توزيعات أرباح قدره ١٫٣٩ %.

Rohto Pharmaceutical Co يُصنف ضمن قطاع 'استهلاك غير دوري'.

لكي تستلم آخر توزيعات أرباح بقيمة ٢٠ JPY من Rohto Pharmaceutical Co المُعلن عنها في ١‏/٦‏/٢٠٢٥، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٨‏/٣‏/٢٠٢٥.

تم توزيع آخر دفعة من الأرباح بتاريخ ١‏/٦‏/٢٠٢٥.

في العام 2024، وزعت Rohto Pharmaceutical Co ٢٤ JPY كأرباح أسهم.

يتم توزيع أرباح Rohto Pharmaceutical Co بالعملة JPY.